Trials / Unknown
UnknownNCT03872986
Caries Sealing Using Giomer and Glass Ionomer Cement With or Without Silver Diamine Fluoride
Clinical Evaluation of Caries Sealing Technique on Primary Teeth Using Giomer and Glass Ionomer Cement (GIC) With or Without Silver Diamine Fluoride (SDF)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Hacettepe University · Academic / Other
- Sex
- All
- Age
- 6 Years – 8 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate and compare the clinical performance of Giomer and GIC restorations with and without SDF on caries sealing of primary molar teeth
Detailed description
Restorations will be placed on four primary molar teeth with occlusal caries, in a split mouth design. 100 patients will be included in the study. The teeth will be randomized into four groups according to the restorative materials. Group 1: SDF (Riva Star) + Giomer (Beautifil II, (Shofu Dental, Tokyo, Japan) Group 2: Giomer (Beautifil II, (Shofu Dental, Tokyo, Japan) Group 3: SDF (Riva Star) + GIC (Equia Forte, GC, Japan) Group 4: GIC (Equia Forte, GC, Japan) The restorations will be evaluated clinically at baseline and 6., 12., 18., 24. months and radiologically at 6., 12. and 24. months. The modified US Public Health Service criteria (secondary caries, marginal integrity, marginal discoloration and retention) will be used for clinical evaluation of restorations. Intra-oral photos will be taken directly after treatment and at control appointments. The data will be analysed statistically using Wilcoxon test, chi square test and the Kaplan-Meier survival method will be used to estimate survival percentages.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SDF | Combined Silver Diamine Fluoride (SDF) and Potassium Iodide (KI) |
| DEVICE | Giomer | Beautifil II dental restorative material |
| DEVICE | GIC | Equia forte dental restorative material |
Timeline
- Start date
- 2021-02-04
- Primary completion
- 2023-12-01
- Completion
- 2024-06-01
- First posted
- 2019-03-13
- Last updated
- 2021-03-15
Locations
2 sites across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT03872986. Inclusion in this directory is not an endorsement.